Journal of Diagnostics Concepts & Practice ›› 2023, Vol. 22 ›› Issue (01): 50-57.doi: 10.16150/j.1671-2870.2023.01.008
• Original articles • Previous Articles Next Articles
QIAN Ying, MA Xiaobo, GAO Chenni, CHEN Zijin, MA Jun, YU Haijin, ZHANG Wen, CHEN Xiaonong()
Received:
2022-12-30
Online:
2023-02-25
Published:
2023-07-06
Contact:
CHEN Xiaonong
E-mail:cxn10419@rjh.com.cn
CLC Number:
QIAN Ying, MA Xiaobo, GAO Chenni, CHEN Zijin, MA Jun, YU Haijin, ZHANG Wen, CHEN Xiaonong. The diagnostic efficiency and application value of fracture risk assessment tools in maintenance hemodialysis patients[J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 50-57.
Table 1
Characteristics of patients with fracture and non-fracture
Index | Total (n=136) | Non-fracture (n=120) | Fracture (n=16) | P |
---|---|---|---|---|
Age (years) | 59 (47-66.75) | 57 (44.25-64.0) | 69 (60.75-75.75) | 0.001 |
Gender (%, female) | 56 (41.2%) | 50 (41.7%) | 6 (37.5%) | 0.794 |
Duration of HD(months) | 55 (26-86.75) | 52.5 (26.0-81.75) | 78.5 (27.5-122.25) | 0.223 |
Body mass index (kg/cm2) | 21.75 (18.84-23.84) | 21.63 (19.12-23.42) | 22.76 (18.00-24.52) | 0.861 |
Laboratory parameters | ||||
Ca (mmol/L) | 2.33 ± 0.25 | 2.33 ± 0.25 | 2.33 ± 0.29 | 0.979 |
P (mmol/L) | 1.81 ± 0.70 | 1.86 ± 0.70 | 1.50 ± 0.54 | 0.051 |
Alkaline phosphatase (IU/L) | 66.50 (54.00-88.50) | 66.00 (53.00-84.00) | 76.50 (58.00-106.75) | 0.114 |
Parathyroid hormone (ng/L) | 265.90 (145.10-535.42) | 252.7 (141.72-538.58) | 338.8 (146.02-523.18) | 0.762 |
25(OH)D3 (nmol/L) | 41.49 (25.55-65.93) | 41.78 (25.62-65.93) | 36.80 (23.00-80.33) | 0.761 |
Diabetes (%) | 30 (22.1%) | 26 (21.7%) | 4 (25.0%) | 0.763 |
Oral glucocorticoid (%) | 30 (22.1%) | 25 (20.8%) | 5 (31.3%) | 0.346 |
Oral calcitriol (%) | 122(90.4%) | 108(90%) | 14(93.3%) | 0.666 |
BMD | ||||
Lumbar spine (L1-L4) (g/cm2) | 1.16 (1.01-1.27) | 1.16 (1.03-1.28) | 1.02 (0.87-1.20) | 0.028 |
Lumbar spine (L1-L4)(T-score) | -0.10(-0.90-0.88) | -0.05(-0.85-1.00) | -0.80(-2.15-0.80) | 0.084 |
Femoral neck (g/cm2) | 0.81 (0.73-0.93) | 0.83 (0.74-0.95) | 0.73 (0.65-0.85) | 0.006 |
Femoral neck (T-score) | -0.90(-1.60-0.00) | -0.80(-1.50-0.05) | -1.55(-2.2--0.90) | 0.004 |
Total hip (g/cm2) | 0.86 (0.77-0.98) | 0.88 (0.78-0.98) | 0.78 (0.660.85) | 0.002 |
Total hip (T-score) | -0.65(-1.40-0.30) | -0.50(-1.30-0.30) | -1.25(-2.15--0.75) | 0.003 |
OSTA | 0.48 (-2.10-3.00) | 0.80 (-1.95-3.2) | -1.68 (-4.1-0.95) | 0.015 |
FRAX2(%) | 3.55 (2.30-5.28) | 3.2 (2.3-4.9) | 5.3 (3.7-6.28) | 0.005 |
FRAX1(%) | 2.90 (1.80-4.38) | 2.7 (1.6-4.2) | 3.8 (2.95-5.75) | 0.010 |
Table 2
Comparison of diagnostic performance of BMD, OSTA, and FRAX models
Indice | AUC (95%CI) | Cutoff value | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|
L1-L4 BMD (g/cm2) | 0.669 (0.583-0.747) | 0.973 | 50.0 (24.7-75.3) | 85.0 (77.3-90.9) |
Femoral neck BMD (g/cm2) | 0.708 (0.624-0.783) | 0.719 | 50.0 (24.7-75.3) | 82.5 (74.5-88.8) |
Total hip BMD (g/cm2) | 0.736 (0.654-0.808) | 0.859 | 87.5 (61.7-98.4) | 54.2 (44.8-63.3) |
OSTA | 0.686 (0.601-0.763) | 0.2 | 75.0 (47.6-92.7) | 55.0 (45.7-64.1) |
FRAX1(%) | 0.715 (0.631-0.789) | 3.3 | 87.5 (61.7-98.4) | 50.8 (41.6-60.1) |
FRAX2(%) | 0.697 (0.613-0.773) | 2.8 | 81.2 (54.4-96.0) | 52.5 (43.2-61.7) |
Table 3
The comparison of AUC for each fracture risk assessment tool (P value)
Indice | BMD(L1-L4) | BMD(FN) | BMD(TH) | OSTA | FRAX1 | FRAX2 |
---|---|---|---|---|---|---|
L1-L4 BMD | 0.309 | — | — | — | — | — |
FN BMD | 0.476 | 0.460 | — | — | — | — |
TH BMD | 0.751 | 0.257 | 0.324 | — | — | — |
OSTA | 0.107 | 0.836 | 0.714 | 0.408 | — | — |
FRAX1 | 0.325 | 0.566 | 0.918 | 0.746 | 0.559 | — |
FRAX2 | 0.387 | 0.690 | 0.835 | 0.521 | 0.882 | 0.720 |
[1] |
HAMPSON G, ELDER G J, COHEN-SOLAL M, et al. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease[J]. Endocrine, 2021, 73(3):509-529.
doi: 10.1007/s12020-021-02735-9 pmid: 33974225 |
[2] | JAFARI M, ANWAR S, KOUR K, et al. T Scores, FRAX, Frailty Phenotype, Falls, and Its Relationship to Fractures in Patients on Maintenance Hemodialysis[J]. Can J Kidney Health Dis, 2021, 8:20543581211041184. |
[3] |
COHEN-SOLAL M, FUNCK-BRENTANO T, UREÑA TORRES P. Bone fragility in patients with chronic kidney disease[J]. Endocr Connect, 2020, 9(4):R93-R101.
doi: 10.1530/EC-20-0039 URL |
[4] |
Kidney Disease: Improving Global Outcomes KDIGO CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)[J]. Kidney Int Suppl, 2017, 7:1-59.
doi: 10.1038/ki.1975.1 URL |
[5] |
LESLIE W D, SCHOUSBOE J T, MORIN S N, et al. Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study[J]. Osteoporos Int, 2020, 31(6):1059-1067.
doi: 10.1007/s00198-019-05274-2 pmid: 32173782 |
[6] |
JIRASIRIRAK S, DISTHABANCHONG S, ONGPHIPH-ADHANAKUL B, et al. Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease[J]. Heliyon, 2022, 8(3):e09158.
doi: 10.1016/j.heliyon.2022.e09158 URL |
[7] | 中华医学会放射学分会骨关节学组, 中国医师协会放射医师分会肌骨学组, 中华医学会骨科学分会骨质疏松学组, 等. 骨质疏松的影像学与骨密度诊断专家共识[J]. 中国骨质疏松杂志, 2020, 26(9):1249-1256. |
Bone and Joint Group of Chinese Society of Radiology, Chinese Association; Musculoskeletal Radiology Society of Chinese Medical Association; Osteoporosis Group of Chinese Orthopedic Association, Medical Association, et al. Consensus on the diagnosis of osteoporosis by imaging and bone mineral density measurement[J]. Chin J Osteoporos, 2020, 26(9):1249-1256. | |
[8] |
WHITLOCK R H, LESLIE W D, SHAW J, et al. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease[J]. Kidney Int, 2019, 95(2):447-454.
doi: S0085-2538(18)30775-0 pmid: 30579724 |
[9] |
EL MIEDANY Y. FRAX: re-adjust or re-think[J]. Arch Osteoporos, 2020, 15(1):150.
doi: 10.1007/s11657-020-00827-z pmid: 32989561 |
[10] |
FAN Z, LI X, ZHANG X, et al. Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study[J]. Clin Interv Aging, 2020, 15:1171-1180.
doi: 10.2147/CIA.S257166 pmid: 32764904 |
[11] |
YOON H E, LEE Y H, LEE J E, et al. Seasonality in hip fracture among haemodialysis patients and kidney transplant recipients in South Korea[J]. Nephrology (Carlton), 2022, 27(12):925-933.
doi: 10.1111/nep.v27.12 URL |
[12] |
WAKASUGI M, KAZAMA J J, KIKUCHI K, et al. Hemodialysis Product and Hip Fracture in Hemodialysis Patients: A Nationwide Cohort Study in Japan[J]. Ther Apher Dial, 2019, 23(6):507-517.
doi: 10.1111/tap.v23.6 URL |
[13] |
GOTO N A, WESTSTRATE A C G, OOSTERLAAN F M, et al. The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis[J]. Osteoporos Int, 2020, 31(1):13-29.
doi: 10.1007/s00198-019-05190-5 pmid: 31720721 |
[14] |
AMBRUS C, ALMASI C, BERTA K, et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis[J]. Int Urol Nephrol, 2011, 43(2):475-482.
doi: 10.1007/s11255-010-9723-x pmid: 20237846 |
[15] |
IIMORI S, MORI Y, AKITA W, et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study[J]. Nephrol Dial Transplant, 2012, 27(1):345-351.
doi: 10.1093/ndt/gfr317 URL |
[16] | 中华医学会骨科学分会. 骨质疏松性骨折诊疗指南(2022年版)[J]. 中华骨科杂志, 2022, 42(22):1473-1491. |
Chinese Orthopaedic Association. Guidelines for the dia-gnosis and treatment of osteoporotic fractures (2022 edition)[J]. Chin J Orthop, 2022, 42(22):1473-1491. | |
[17] | 张燕妮, 夏梦迪, 王宝福, 等. 初步探讨超声测量BMD、FRAX(R)和OSTA评定维持性血液透析患者骨折风险[J]. 临床肾脏病杂志, 2018, 18(1):38-42. |
ZHANG Y N, XIA M D, WANG B F, et al. Ultrasonic measurement of BMD, FRAX(R) and OSTA in the prediction of fracture risk in maintenance hemodialysis[J]. J Clin Nephrol, 2018, 18(1):38-42. | |
[18] |
PATRO S K, PAWAR N, BISWAS D. A study to predict fracture risk using bone mineral density and FRAX score in patients on chronic maintenance haemodialysis[J]. J Family Med Prim Care, 2022, 11(1):170-175.
doi: 10.4103/jfmpc.jfmpc_901_21 pmid: 35309612 |
[19] | 王琰, 罗静, 苗金红. 血液净化中心维持性血液透析患者骨质疏松危险因素分析及骨折风险预测[J]. 热带医学杂志, 2022, 22(3):373-377. |
WANG Y, LUO J, MIAO J H. Risk factors of osteoporosis in maintenance hemodialysis patients in blood purification center and prediction of fracture risk[J]. J Trop Med, 2022, 22(3):373-377. | |
[20] | 左薇, 费琦, 杨雍, 等. BMD、OSTA与FRAX®预测绝经后女性骨质疏松性骨折风险的比较研究[J]. 中国骨质疏松杂志, 2015(1):48-52. |
ZUO W, FEI Q, YANG Y, et al. Comparative study of BMD, OSTA, and FRAX in the prediction of osteoporotic fracture risk in postmenopausal women[J]. Chin J Osteoporos, 2015, 21(1):48-52. | |
[21] | 朱再胜, 章振林. 骨折风险评估工具(FRAX®)对绝经后低骨量女性骨折的预测价值[J]. 中华骨质疏松和骨矿盐疾病杂志, 2013, 6(3):213-218. |
ZHU Z S, ZHANG Z L. Fracture predictive values of FRAX® for low bone mass of postmenopausal women[J]. Chin J Osteoporos Bone Miner Res, 2013, 6(3):213-218. | |
[22] | JAFARI M, ANWAR S, KOUR K, et al. T Scores, FRAX, Frailty Phenotype, Falls, and Its Relationship to Fractures in Patients on Maintenance Hemodialysis[J]. Can J Kidney Health Dis, 2021, 8:20543581211041184. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||